OverviewChartNewsTraderScreen

Open End-Turbo-Optionsschein auf .../  DE000HS7PP66  /

gettex Zettex2
7/1/2024  3:51:01 PM Chg.- Bid4:36:59 PM Ask4:36:59 PM Underlying Strike price Expiration date Option type
0.5900EUR - -
Bid Size: 25,000		 -
Ask Size: 25,000		 AMGEN INC. DL-... 313.80 - 12/31/2078 Call
TeleTrader 8/1 Dow jumps 250 pts as Meta surges more than 10%
GlobeNewswire 7/1 Zenas BioPharma Appoints Orlando Oliveira as Chief Commercial Officer
GlobeNewswire 6/27 Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 M...
GlobeNewswire 6/27 Coherus BioSciences Announces Divestiture of YUSIMRY (adalimumab-aqvh) in a $40 Million Upfront All ...
GlobeNewswire 6/26 COUR Pharmaceuticals Appoints Tim Walbert to its Board of Directors
GlobeNewswire 6/26 Compass Pathways appoints Lori Englebert as Chief Commercial Officer
GlobeNewswire 6/25 Arthritis Foundation Launches Carolina Hills Classic Bike Tour, Coming June 2025
TeleTrader 6/24 US closes mostly lower, as energy, banking stocks take lead
GlobeNewswire 6/20 Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach $7...
GlobeNewswire 6/19 Jasper Therapeutics Announces Appointment of Svetlana Lucas Ph.D., to its Board of Directors
GlobeNewswire 6/18 CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Confere...
GlobeNewswire 6/17 CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer
GlobeNewswire 6/17 FDA Approves Phase II Clinical Trial for Ruxoprubart in ANCA Associated Vasculitis (AAV) – a Chronic...
GlobeNewswire 6/17 Solid Power Appoints Renewables Industry Veteran Linda Heller as Chief Financial Officer
GlobeNewswire 6/5 Coherus BioSciences Appoints Rita Karachun, CPA, CGMA to its Board of Directors
GlobeNewswire 5/30 Crinetics Pharmaceuticals Appoints Robert M. Cuddihy, M.D., as Senior Vice President of Medical Affa...
TeleTrader 5/28 US markets turn to losses, Dow plunges 330 points
TeleTrader 5/28 Wall Street opens mostly higher as T+1 stock trading returns
GlobeNewswire 5/28 Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD
GlobeNewswire 5/27 Samsung Bioepis Announces Oral Presentation on Switching Period Results for SB16, a Proposed Biosimi...
GlobeNewswire 5/23 Coherus Presents Preliminary Results from Phase I Dose Escalation Study of its Anti-chemokine recept...
GlobeNewswire 5/22 CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference
GlobeNewswire 5/22 Sandoz receives European Commission approval for Wyost® and Jubbonti®, the first and only biosimilar...
GlobeNewswire 5/21 Alvotech Reports Financial Results for First Quarter of 2024 and Provides a Business Update
GlobeNewswire 5/21 Alvotech and Dr. Reddy’s enter into collaboration for commercialization of AVT03 (denosumab), a bios...